We are a biopharmaceutical company engaged in the development and commercialization of premium cannabinoid-based nutraceuticals and pharmaceuticals

STOCK QUOTE – CNX: PVOT


 

STOCK QUOTE – OTCQB: PVOTF


LATEST NEWS


 

Our Consumer Facing Bio-Cannabis Product Line

CBD | CBD+THC | THC

Capsules & Tablets Bulk Powder Stick Packs Beverages Water Soluble Oral Solutions
Lotions, Creams & Gels Pet Food Additives

Welcome to Our Family of Brands

 

Pivot has a holistic approach to business. Our three divisions are structured to efficiently and quickly achieve business goals through procurement, manufacturing and supply & distribution

Pivot Pharmaceuticals is Poised to Become a Strategic Winner in the Exploding Cannabis Market

 

With legislation changing rapidly, Pivot is positioned to take advantage of the rapid growth in the Canadian, Californian and International Markets. The legal international cannabis market is expected to grow more than 1000 percent within the next 10 years, reaching $140 billion by 2027*. Our strategy is threefold:

 

Procurement Manufacturing Supply & Distribution

Our Markets

California Colorado Canada Europe

Our Technologies

 

Pivot has acquired worldwide rights for four proprietary drug delivery technologies for the delivery and commercialization of cannabinoid, cannabidiol and tetrahydrocannabinol-based products

Thrudermic™

TRANSDERMAL NANOTECHNOLOGY
FOR CANNABINOIDS

1% CBD NANO-PARTICULATE CREAM
READY FOR COMMERCIALIZATION

Solmic™

MICELLE ORAL DRUG DELIVERY TECHNOLOGY
FOR CANNABINOIDS

1% CBD >99% PURE
READY FOR COMMERCIALIZATON

BiPhasix™

TOPICAL DELIVERY TECHNOLOGY
FOR CANNABINOIDS

1% CBD BIPHASIX CREAM
READY FOR COMMERCIALIZATION

RTIC™

TECHNOLOGY FOR TRANFORMATION OF
CANNABIS OIL TO POWDER

READY TO INFUSE CANNABIS POWDER FOR USE IN CAPSULES, STICK PACKS, BULK POWDER, BEVERAGES, BAKED GOODS

COMING SOON

TriVair™

NASAL AND PULMONARY BREATH-PROPELLED,
MULTI-DIRECTIONAL DRUG DELIVERY SYSTEMS™

RTIC Cannabis Powder Combined with the TriVair™ Delivery System

Each technology platform allows Pivot to produce multiple products

Investor Overview

 

Pivot Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Our shares are publicly-traded on the CNX under the ticker symbol “PVOT” and on the OTCQB under the ticker symbol “PVOTF”

Our Leadership Team

 

Pivot has assembled a highly experienced management team that has clinical, commercial, product development and financial experience

Email:

info@pivotpharma.com

Corporate Address:

#300-1275 West 6th Avenue
Vancouver, BC, V6H 1A6, CAN

Montreal Office:

285 Kesmark, Dollard des Ormeaux
Montreal, QC, H9B 3J1, CAN

U.S. Office:

Pivot Naturals, LLC: 
3595 Cadillac Ave #101
Costa Mesa, CA, 92626, USA

Investor Relations:

Virtus Advisory Group Inc.
1 First Canadian Place, 100 King West, Suite 5600
Toronto, ON, M5X1C9, CAN
Tel:416-644-5081 | Fax:416-644-8801
E: ccohen@virtusadvisory.com

 

Contact Us

1 + 1 =